Market Trends of Global Bariatric Surgery Industry
Gastric Balloon is Expected to Witness a Healthy Growth During the Forecast Period
A gastric balloon, an intragastric balloon (IGB), or a stomach balloon is an inflatable medical device temporarily placed in the stomach to assist with weight loss.
Several factors are driving demand in this segment, including the launch of new products, increasing patient awareness, growing collaborations with bariatric surgery centers, and the various benefits these balloons offer during bariatric procedures.
According to a January 2023 article published by StatPearls (NCBI), the intragastric balloon is recognized as one of the safest and most effective weight-loss therapies available. This minimally invasive, temporary approach helps induce weight loss in obese patients by inserting a soft saline or air-filled balloon into the stomach, typically via endoscopy. The balloon acts as a restrictive mechanism, occupying space in the stomach and promoting a sensation of fullness.
In addition, the proven roles of gastric balloons in reducing body fats and obesity are projected to augment segment expansion during the study period. For instance, according to a study published by the Archive of "Arquivos Brasileiros de Cirurgia Digestiva” in May 2023, intragastric fluid-filled balloons effectively promoted weight loss over 12 months and significantly reduced body mass index and improved body composition measurements. This study highlighted the role of gastric balloons in reducing body mass index, and such benefits from them are expected to propel the adoption, which, in turn, is anticipated to bolster industry expansion over the coming years.
In addition, the prominent players are actively participating in the launch of various gastric balloons, augmenting segment growth. For instance, in September 2022, Allurion launched the Allurion Swallowable Capsule in India, the only medical weight-loss device fully approved by the Central Drugs Standard Control Organization (CDSCO), the national regulatory authority of India.
Also, the growing adoption of gastric balloons in the management of obesity is expected to widen their adoption rates. For instance, in January 2024, two NHS patients received a weight-loss balloon to manage obesity issues in the United Kingdom. Such rising use of gastric balloons to manage increased weights is expected to spur segment uptake during the study period.
Therefore, the abovementioned factors, such as the growing utilization of gastric balloons in weight loss of obese patients and the introduction of new products by the market players, are expected to fuel market growth during the study period.
North America is Expected to Hold Significant Market Share In the Bariatric Surgery Market During the Forecast Period
North America is expected to exhibit a lucrative growth rate in the overall bariatric surgery market due to factors such as the increasing prevalence of obesity, growing demand for obesity treatment, and advanced healthcare infrastructure. In addition, growing initiatives from public and private organizations to promote awareness of obesity in the region are expected to facilitate market uptake in North America.
The growing concerns about obesity in North America are expected to boost the expansion of industry in the region. For instance, according to the 2023 annual report published by the World Obesity Atlas, the annual rate of adult obesity increase is projected to be 2.3% from 2020 to 2035 in Canada, and it is estimated that around 49% of adults are expected to be living with obesity by 2035 in the country. This alarming rise in the burden of obesity is projected to facilitate the adoption of bariatric surgeries, and this is expected to propel market growth during the study period.
Moreover, the long-term safety associated with metabolic and bariatric surgical procedures is expected to increase adoption in the region. For instance, according to an article published by the Surgery for Obesity and Related Diseases in December 2022, bariatric surgery has demonstrated long-term safety, efficacy, and durability in managing clinically severe obesity and its comorbidities. The benefits associated with these surgeries have facilitated people to go for such surgeries, and this trend is likely to benefit industry expansion in the coming years.
Thus, the high prevalence of obesity, the increasing adoption of bariatric surgeries in the United States, and increasing product developments are expected to drive the bariatric surgery market during the forecast period.
